On 11 January 2019, orphan designation (EU/3/18/2133) was granted by the European Commission to TLC Biopharmaceuticals B.V., the Netherlands, for vinorelbine tartrate for the treatment of soft tissue sarcoma.
|Disease / condition||
Treatment of soft tissue sarcoma
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.